In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported

by Tauangtham Anekpuritanang, Matthew M. Klairmont, Joel Gradowski, Kohei Hagiwara, Nathanael G. Bailey, Pranil Chandra, Yiwei Liu, Heather L. Mulder, John Easton, Jinghui Zhang, Michael G. Martin, Anna B. Owczarczyk, Jennifer B. Dunlap, Guang Fan, Richard D. Press, Philipp W. Raess
Published 2022